Shire, the London-listed pharmaceuticals group, has moved to bolster its rare disease treatment business with the $4.2bn acquisition of ViroPharma. Ireland-domiciled Shire will pay $50 a share in cash ...

Glenn Tillotson is a full-time employee of ViroPharma Incorporated, PA, USA. Alan Tice has received income for research and consulting from Replidyne, Pfizer and Astellas. This work has been ...

Shire's acquisition of Viropharma last year helped its sales and earnings rocket in 2014, although chief executive Flemming Ornskov said growth in 2015 will be slower. Full-year sales grew 23 per ...

Five at Five: FTSE 100 powers on to new record, Trump sweeps away Biden regime, Meme coin makes him billions, House prices soar ...